Tag: asthma-emergency care

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ORAL MONTELUKAST IN ACUTE ASTHMA EXACERBATION

FCAAIA Notes: This study doesn’t actually show any new data.  It has been known for years that in conjunction with usual care, montelukast (commercially known by its brand name, Singulair) is no more effective than placebo for acute asthma flares.  This particular study of adults showed that montelukast did not shorten hospitalization or contribute to improving lung function in adults.  There are also no data to suggest its role in children who have a significant asthma flare. Continue reading “A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ORAL MONTELUKAST IN ACUTE ASTHMA EXACERBATION”

Skip to content